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Case ReportsRight video-assisted thoracoscopy thoracic duct ligation as treatment
for a case of chyloptysisRobert B. Xu, MBBS, Gareth Crouch, MBBS, Craig Jurisevic, FRACS, and Robert G. Stuklis, FRACS,
Adelaide, AustraliaWe describe a case of chyloptysis as a consequence of tho-
racic duct injury after aortic arch surgery and its subsequent
management.
CLINICAL SUMMARY
A 71-year-old man presented with ongoing expectoration
of milky, foul-tasting sputum, while denying any systemic
symptoms. He first presented in 2007 with a type B dissec-
tion with an aneurysmal complex. He underwent distal aor-
tic arch repair via a left anterolateral thoracotomy approach
with femoral-femoral bypass via percutaneous cannulas.
The distal aortic arch was transected and a 26-mm Dacron
graft was sutured, with a distal anastomosis formed below
the pulmonary hilum to the distal descending thoracic aorta.
The left subclavian artery was resected as high as possible,
anastomosed to an 18-mm Gelseal (Terumo Cardiovascular
Systems Corp, Ann Arbor, Mich) graft that was then at-
tached to the aortic graft. The patient was returned to the op-
erating room postoperatively for evacuation of a hematoma,
after which he progressed well and was transferred out of
the intensive care unit.
On day 14, a progressive left pleural effusion was con-
firmed on computed tomography and tapped using needle
thoracostomy. Biochemistry of the specimen confirmed a di-
agnosis of chylothorax, with a protein level of 22 g/L, an LD
level of 530 U/L, and a triglyceride level of 8.3 mmol/L,
meeting the diagnostic criteria determined by the Mayo
Clinic (>1.24 mmol/L or 110 mg/dL).1
After a trial of conservative therapy, including tube thor-
acostomy drainage and 2 weeks of a medium chain-
triglyceride diet with octreotide adjunct, the chyle leak
persisted and the patient received surgical intervention via
redo thoracotomy.From the Darcy Sutherland Cardiothoracic Surgical Unit, Royal Adelaide Hospital,
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around the distal left subclavian anastomosis. This was
controlled with pledgeted sutures (Ethicon, Somerville, NJ)
and biological glue (Tisseel; Immuno AG, Vienna, Austria).
After surgical correction, the chyle leak resolved with the
drains removed on day 3. The remainder of the admission
was uneventful, and the patient was discharged on day 34.
After discharge, the patient was noted to have a reaccu-
mulation of fluid in his left pleural cavity noted on
follow-up imaging at 1 year, likely due to a persistent chy-
lothorax. This was compounded by a frequent irritating pro-
ductive cough, prompting re-referral for cardiothoracic
surgical opinion 4 years after his original operation.
The sputum was noted by the patient to be a milky liquid.
Sputum samples were submitted for pathologic testing,
which although diluted nevertheless displayed a cholesterol
level less than 0.5mmol/L, triglyceride level of 1.1 mmol/L,
and cholesterol to triglyceride ratio greater than 2.2, sugges-
tive of chyle; pleural fluid also was collected (Figure 1),
with a triglyceride level of 11.0 mmol/L. Confirmatory chy-
lomicron testing was not available through our pathology
service. A nuclear lymphoscintigram also was performed,
but because the chylothorax was a slow leak, there was no
evidence of tracer uptake into the thoracic cavity on the
limited duration of the scan. The diagnosis was a chylous
pleural effusion complicated by a mediastinal-bronchial
communication. The patient proceeded to right video-
assisted thoracoscopy and successful ligation of the
thoracic duct with ligating clips (Ethicon, Somerville, NJ)
(Figure 2).RESULTS
At 1-year follow-up, the patient was well with no reaccu-
mulation of pleural fluid on imaging or recurrence of pro-
ductive cough.
Chyloptysis is a rare condition that has been reported to
occur spontaneously on a background of mediastinal lym-
phatic disorders, including lymphangioleiomyomatosis
and thoracic lympangiectasis.2 However, iatrogenic injury
also can be a cause, as in this case in which injury to the tho-
racic duct leading to chylous pleural effusion with coexist-
ing mediastinal-bronchial fistula facilitates chyloptysis, one
of the accepted mechanisms.3 Because the thoracic duct has
a highly variable course, it is prone to injury, especially in
esophageal or aortic surgery.ery c June 2013
FIGURE 1. Chylous pleural fluid sample.
FIGURE 2. Thoracic duct ligation at video-assisted thoracic surgery.
Case ReportsSymptoms will include expectoration of milky-white,
foul-tasting sputum. However, the degree of production
will be variable and not necessarily postprandial or linked
with fatty food consumption. Lymphangiograms can aid
in the diagnosis, although this is dependent on the speed
of accumulation of the chyle leak. Where it is not available,
radionuclide lymphoscintigraphy, normally reserved for
imaging of malignant disease or lymphedema of the ex-
tremities, also can be used to visualize abnormalities of
the thoracic duct.4
CONCLUSIONS
Iatrogenic injury to the thoracic duct is a not an uncom-
mon consequence of thoracic cavity surgery. We present
a case of such an injury after distal aortic arch repair, with
persistent chylothorax and chyloptysis as a consequence.From the Thoracic Surgery and Lung Transplantation Unit, University Hospital Reina
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The Journal of Thoracic and CaAlthough the preference of the original treating surgeon
was to attempt surgical correction via redo thoracotomy,
in this case right-assisted video-assisted thoracoscopy
duct ligation was used as a successful conclusive treatment
modality. Because video-assisted thoracic surgery has a rel-
atively low morbidity and cost, earlier use of this approach
is supported by the literature.5
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